A novel combination of bortezomib, lenalidomide, and clarithromycin produced stringent complete response in refractory multiple myeloma complicated with diabetes mellitus – clinical significance and possible mechanisms: a case report
ConclusionsThe successful dexamethasone-free regimen clearly shows that dexamethasone is not a requisite component in treating multiple myeloma, and it can be substituted with clarithromycin. This regimen is particularly useful for treating patients with multiple myeloma associated with diabetes mellitus.
Source: Journal of Medical Case Reports - Category: General Medicine Source Type: research
More News: Biaxin | Clarithromycin | Dexamethasone | Diabetes | Diabetes Mellitus | Endocrinology | General Medicine | Insulin | Japan Health | Myeloma | Revlimid | Velcade